CANSINOBIO (06185) announced its financial results for the three months ended March 31, 2026. The company reported an operating revenue of 190 million yuan, representing a year-on-year increase of 38.73%. However, the net loss attributable to shareholders reached 40.4243 million yuan, marking a significant expansion of 250.13% compared to the same period last year. The basic loss per share was 0.16 yuan.